Skip to main content
. Author manuscript; available in PMC: 2013 Apr 10.
Published in final edited form as: J Control Release. 2012 Jan 20;159(1):111–119. doi: 10.1016/j.jconrel.2012.01.010

Fig 4.

Fig 4

Transfection efficiency and cell viability for each polymer formulation were assessed in CT-26 cells. bPEI25k was used at 0.5/1 and 1/1 w/w ratio for transfections. The other formulations were used at 12/1 w/w. The RLU/mg protein was not included for bPEI 1/1 due to the significant toxicity observed. Data are represented as mean ± SD, *p < 0.05 for 1-way ANOVA using a Tukey’s post-hoc test (n=6).